“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice
Open Access
- 22 March 2026
- journal article
- Published by Taylor & Francis in Drugs: Education, Prevention and Policy
- p. 1-16
Abstract
No abstract availableFunding Information
- National Health and Medical Research Center (2041822)
- ARC DECRA (DE250101115)
This publication has 81 references indexed in Scilit:
- Mitigating Ethical Issues in Training for Psychedelic TherapyNeuroethics, 2025
- Mapping the risk environment for peers with lived-living experience working in the alcohol and other drugs sector in QueenslandInternational Journal of Drug Policy, 2025
- How do relational practices co-constitute care for people who use drugs? The social and political dimensions of peer-led harm reductionInternational Journal of Drug Policy, 2024
- Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit AnalysisHastings Center Report, 2024
- Mindfulness meditation and psychedelics: potential synergies and commonalitiesPharmacological Reports, 2023
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current researchAddiction Neuroscience, 2022
- A systematic review and meta‐synthesis of qualitative research into mandatory personal psychotherapy during trainingCounselling and Psychotherapy Research, 2018
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-upPsychopharmacology, 2017
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significancePsychopharmacology, 2006